Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-060311

Chief Executive Officer sold 7,800 shares at an average $40.39 ($315,035)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-11-28 Sale −2,700 $38.65 $104,355 32,578 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-11-28 Sale −1,200 $39.54 $47,448 31,378 I: show line 2 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-11-29 Sale −1,400 $41.13 $57,582 29,978 I: show line 3 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-11-29 Sale −2,500 $42.26 $105,650 27,478 I: show line 4 in the form
Open-market sales · 7,800 sh · avg $40.39 · $315,035
Loading xslF345X03/doc4.xml…